A study for a 46 year old woman who takes Tegretol, Duloxetine Hydrochloride, Cellcept - from FDA reports


195 females aged 46 (±5) who take the same drugs are studied. This is a personalized study for a 46 year old female patient who has Chronic Depression, Depression, Systemic Lupus Erythematosus. The study is created by eHealthMe based on reports from FDA.



On Apr, 16, 2018

195 females aged 46 (±5) who take Tegretol, Duloxetine Hydrochloride, Cellcept are studied.


Number of reports submitted per year:

Tegretol, Duloxetine Hydrochloride, Cellcept for a 46-year old woman.

Information of the patient in this study:

  • Age: 46
  • Gender: female
  • Conditions: Chronic Depression, Depression, Systemic Lupus Erythematosus
  • Drugs taken:
    • Tegretol (carbamazepine)
    • Duloxetine Hydrochloride (duloxetine hydrochloride)
    • Cellcept (mycophenolate mofetil)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • Hair loss
  • Hoarseness or changing voice
  • Rashes (redness)
  • Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  • Osteomyelitis (infection of bone)
  • Glycosylated haemoglobin increased
  • Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  • Aspartate aminotransferase increased
  • Pharyngitis (inflammation of the pharynx, causing a sore throat)
  • Insomnia (sleeplessness)
1 - 6 months:
  • Coronary heart disease (narrowing or blockage of the coronary arteries)
  • Type 2 diabetes
  • Therapeutic response unexpected
  • Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  • Fatigue (feeling of tiredness)
  • Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  • Tardive dyskinesia (a disorder that involves involuntary movements)
  • Migraine (headache)
  • Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  • Disturbance in attention
6 - 12 months:
  • Suicidal ideation
  • Meniere's disease (a disorder of the inner ear that can affect hearing and balance to a varying degree)
  • Neuralgia (pain in one or more nerves)
  • Urinary tract infection
  • Weakness
  • Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  • Blood creatine phosphokinase increased
  • Balance disorder
  • Interstitial lung disease
  • Injury
1 - 2 years:
  • Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  • Type 2 diabetes
  • Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  • Coronary heart disease (narrowing or blockage of the coronary arteries)
  • Tardive dyskinesia (a disorder that involves involuntary movements)
2 - 5 years:
  • High blood pressure
  • Stroke (sudden death of a portion of the brain cells due to a lack of oxygen)
  • Fainting (loss of consciousness and postural tone)
  • Cardiac disorder
  • Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  • Hypoglycemia (low blood sugar)
  • Interstitial lung disease
  • Hyperglycemia (high blood sugar)
  • High blood cholesterol
  • Diabetes
5 - 10 years:
  • Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  • Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death)
10+ years:
  • Weight decreased
  • Asthma
  • Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  • Feeling abnormal
  • Diarrhea
  • Therapeutic response unexpected
  • Nausea (feeling of having an urge to vomit)
  • Pre-existing condition improved
  • Hypoaesthesia (reduced sense of touch or sensation)
  • Nausea and vomiting
not specified:
  • Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  • Drug ineffective
  • Fatigue (feeling of tiredness)
  • Pain
  • Fall
  • Rashes (redness)
  • Insomnia (sleeplessness)
  • Balance disorder
  • Drug hypersensitivity
  • Breathing difficulty

Top conditions involved for these people *:

  • Pain : 28 people, 14.36%
  • Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 28 people, 14.36%
  • High Blood Cholesterol : 21 people, 10.77%
  • Thyroid Diseases : 20 people, 10.26%
  • Constipation : 20 people, 10.26%

Top co-used drugs for these people *:

  • Lyrica (48 people, 24.62%)
  • Baclofen (36 people, 18.46%)
  • Seroquel (31 people, 15.90%)
  • Provigil (27 people, 13.85%)
  • Klonopin (27 people, 13.85%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Related tests

We suggest these affordable tests for self monitoring. You can order them and receive results on eHealthMe. No doctor referral or insurance necessary.

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?



Related studies:

Related publications that referenced our studies

Can you answer these questions?

More questions for: Tegretol, Duloxetine hydrochloride, Cellcept, Chronic depression, Systemic lupus erythematosus, Depression

You may be interested in these posts

More posts for: Tegretol, Duloxetine hydrochloride, Cellcept, Chronic depression, Systemic lupus erythematosus, Depression

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.